Discovering New Ways to Measure Health and Disease
Official title: Core E - Translational Biomarker Core
Funded at Cleveland Clinic Foundation · NIH-11169755 · Data updated 2026-11-12
This core facility helps researchers discover and use special biological markers to better understand diseases and how treatments affect patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cleveland Clinic Foundation NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project start | September 1, 2015 |
| Project end | June 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $56,713 |
| NIH project number | 5P20GM109025-10 |
| Project ID | NIH-11169755 on NIH RePORTER |
Who could benefit from this research
✓Could help
This core supports a wide range of research, so specific patient populations would depend on the individual studies it assists.
✕Less likely to help
Patients not involved in studies supported by this core, or those with conditions not currently being investigated by its partner projects, may not directly benefit from this specific core's activities.
What this research studies
This "Translational Biomarker Core" is like a specialized lab that supports many different health studies. Its main goal is to help scientists find and use "biomarkers," which are signs in your body, like in blood or tissue, that can tell us about your health or how a disease is progressing. By identifying these markers, researchers can get a clearer picture of what's happening at a biological level. This information can then be used to develop new diagnostic tests, track the effectiveness of treatments, or even predict how a disease might behave. Ultimately, this core helps speed up the process of turning lab discoveries into real benefits for patients.
Why it matters
Potential benefit: If successful, this core's work could lead to new ways to diagnose diseases earlier, monitor treatment effectiveness more precisely, and personalize care for patients.
How similar studies have gone: Biomarker discovery and validation are well-established fields, and many successful treatments and diagnostic tools have emerged from similar core facilities supporting translational research.
Where this research is happening
-
Cleveland Clinic Foundation
Cleveland, United States Active
Researchers
- Principal investigator: Kinney, Jefferson — Cleveland Clinic Foundation
- Study coordinator: Kinney, Jefferson
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.